Viewing Study NCT05177133


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2025-12-26 @ 1:33 AM
Study NCT ID: NCT05177133
Status: RECRUITING
Last Update Posted: 2024-08-02
First Post: 2021-09-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-11-05
Start Date Type: ACTUAL
Primary Completion Date: 2025-05-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-11-04
Completion Date Type: ESTIMATED
First Submit Date: 2021-09-07
First Submit QC Date: None
Study First Post Date: 2022-01-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-01
Last Update Post Date: 2024-08-02
Last Update Post Date Type: ACTUAL